Podcast episode 5 (in German)
SLU-PP-332: exercise in a syringe? The training molecule fact-checked
July 12, 2026
SLU-PP-332 is meant to make the body believe it has just completed a long endurance session. The small laboratory molecule presses a switch otherwise flipped by training and delivers astonishing results in mice. It has not yet been tested in humans.
What it is about
SLU-PP-332 is not a peptide but a small synthetic molecule from the group around the pharmacologist Thomas Burris; the abbreviation stands for Saint Louis University. It activates the ERR receptors, master regulators of energy metabolism which, despite their name, have little to do with estrogen. These switches control how many mitochondria a cell builds and how well it burns fat, and they are exactly the ones that also kick in during endurance training. That is why SLU-PP-332 is considered an exercise mimetic, an imitator of exercise. The episode explains the mechanism, goes through the mouse data and shows the medical vision behind it. At the end stands an elegant idea that has yet to prove in humans what it shows in mice.
Key points
- In mouse experiments by Billon and colleagues, animals given SLU-PP-332 ran markedly longer and farther without prior training, in the order of roughly half again as much endurance performance.
- The treated mice burned more fat and had higher energy expenditure; in models of overweight, the molecule helped with fat loss without the animals eating less.
- SLU-PP-332 increased the proportion of enduring, fatigue-resistant type 1 muscle fibers, as characteristic of marathon runners: a remodeling of the muscle toward endurance.
- During training, the conductor PGC-1-alpha gives the cues, and the ERR switches translate them into genes for mitochondria and fat burning; SLU-PP-332 acts directly on these switches.
- MOTS-c acts more via the energy sensor AMPK, SLU-PP-332 via the ERR switches: two doors to more mitochondrial fitness, while retatrutide is a hormonal route to weight loss.
- The medical vision goes beyond sport: muscle wasting, metabolic diseases and perhaps heart failure, that is, wherever exercise would help but is not possible.
- Mainly 3 groups are interested: endurance athletes who want to amplify their training effect, the fat-burning faction and longevity users who care about mitochondria.
Where the data stop
So far the data come almost exclusively from animal experiments; as of July 2026, SLU-PP-332 has not been tested in humans. This means reliable safety data are also lacking, and the existing user reports are anecdotal. Known from research is a rather short duration of action in the body; everything else is open in humans.
Legally, SLU-PP-332 is a research chemical, not approved as a medicine and not released for human use. Anyone competing should check its prohibited status. Combinations with other substances in so-called stacks are experimental uncharted territory, and for healthy people real training remains the first choice. What remains is a precisely designed tool at a sensible point, whose benefit in humans is still pending.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on July 12, 2026.
The topic in the database
- An “exercise mimetic”: in the lab it activates the cellular energy switches (ERR). More endurance and fat loss are so far exclusively mouse data SLU-PP-332
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.